phase 1_2_initiation
saveInstitute of Hematology & Blood Diseases Hospital — azacitidine (Phase I/II Trial Initiation)
community read0 votes
Therapy area: Oncology. Indication: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia), Myelodysplastic Syndrome (Preleukemia)